Antonio Braga Selected Research

Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational)

4/2022	Emotional and Clinical Aspects Observed in Women with Gestational Trophoblastic Disease: A Multidisciplinary Action.
1/2022	Perinatal outcomes of first pregnancy after chemotherapy for gestational trophoblastic neoplasia: a systematic review of observational studies and meta-analysis.
11/2021	A novel alternative to cytotoxic chemotherapy for gestational trophoblastic disease.
7/2021	Treatment of high-risk gestational trophoblastic neoplasia and chemoresistance/relapsed disease.
1/2021	Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study.
1/2021	Folinic acid rescue during methotrexate treatment for low-risk gestational trophoblastic neoplasia - How much is just right?
1/2021	Distinct microRNA profiles for complete hydatidiform moles at risk of malignant progression.
1/2020	Outcomes in the management of high-risk gestational trophoblastic neoplasia in trophoblastic disease centers in South America.
1/2020	Comparison of treatment for low-risk GTN with standard 8-day MTX/FA regimen versus modified MTX/FA regimen without chemotherapy on the weekend.
1/2019	Can carboplatin or etoposide replace actinomycin-d for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia?

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio Braga Research Topics

Disease

20	Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational) 04/2022 - 07/2015
11	Hydatidiform Mole (Molar Pregnancy) 01/2021 - 07/2015
3	Choriocarcinoma 01/2021 - 01/2018
2	Hemorrhage 04/2021 - 05/2016
2	Uterine Hemorrhage (Uterine Bleeding) 04/2021 - 01/2021
2	Neoplasms (Cancer) 01/2021 - 01/2018
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2018
1	Spontaneous Abortion (Miscarriage) 01/2022
1	Stillbirth 01/2022
1	Hyperthyroidism 01/2022
1	Cysts 01/2022
1	Lymphopenia (Lymphocytopenia) 01/2019
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Vomiting 01/2019
1	Anemia 01/2019
1	Febrile Neutropenia 01/2019
1	Uterine Perforation 04/2018
1	Myasthenia Gravis 01/2018
1	Disease Progression 01/2018
1	Pre-Eclampsia (Preeclampsia) 05/2016
1	Uterine Prolapse (Vaginal Prolapse) 11/2014
1	Pelvic Organ Prolapse 11/2014
1	Intraoperative Complications 11/2014
1	Prolapse 11/2014

Drug/Important Bio-Agent (IBA)

13	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 01/2021 - 07/2015
4	Methotrexate (Mexate)FDA LinkGeneric 04/2021 - 01/2019
3	Etoposide (VP 16)FDA LinkGeneric 07/2021 - 01/2019
3	Leucovorin (Folinic Acid)FDA Link 01/2021 - 01/2019
2	Dactinomycin (Actinomycin)FDA LinkGeneric 04/2021 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
1	LuteinIBA 01/2022
1	Vincristine (Oncovin)FDA LinkGeneric 04/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Formaldehyde (Formol)FDA Link 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	ParaffinIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	human ERBB2 proteinIBA 01/2020
1	Carboplatin (JM8)FDA LinkGeneric 01/2019
1	Indicators and Reagents (Reagents)IBA 04/2018
1	Hemoglobins (Hemoglobin)IBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Caspase 3 (Caspase-3)IBA 01/2016
1	SurvivinIBA 01/2016

Therapy/Procedure

14	Drug Therapy (Chemotherapy) 04/2022 - 01/2016
2	Blood Transfusion (Blood Transfusions) 04/2021 - 05/2016
2	Therapeutics 01/2021 - 01/2021
2	Operative Time 01/2018 - 11/2014
1	Length of Stay 01/2018
1	Hormonal Contraception 11/2017
1	Gynecologic Surgical Procedures (Gynecologic Surgery) 11/2014
1	Hysterectomy 11/2014